François Roberge
Chief Executive Officer at LSL PHARMA GROUP INC.
Net worth: 270 413 $ as of 2024-04-29
François Roberge active positions
Companies | Position | Start | End |
---|---|---|---|
LSL PHARMA GROUP INC. | Chairman | - | - |
Chief Executive Officer | - | - | |
President | - | - | |
Director/Board Member | - | - | |
Public Communications Contact | - | - | |
Laboratoire LSL, Inc.
Laboratoire LSL, Inc. Pharmaceuticals: MajorHealth Technology Laboratoire LSL, Inc. develops and manufactures food supplements and vitamins and sterile injectable ophthalmic pharmaceutical products. It offers turnkey projects tailored. The company is headquartered in Longueuil, Canada. | President | 2012-12-31 | - |
Career history of François Roberge
Former positions of François Roberge
Companies | Position | Start | End |
---|---|---|---|
JAMP Pharma Corp.
JAMP Pharma Corp. Pharmaceuticals: GenericHealth Technology JAMP Pharma Corp. develops pharmaceutical products. The private company is based in Boucherville, Canada. The Canadian company was founded in 1988. The CEO is Louis Pilon. | Director of Finance/CFO | 2006-12-31 | 2014-11-30 |
Statistics
International
Canada | 3 |
2 |
Operational
President | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Laboratoire LSL, Inc.
Laboratoire LSL, Inc. Pharmaceuticals: MajorHealth Technology Laboratoire LSL, Inc. develops and manufactures food supplements and vitamins and sterile injectable ophthalmic pharmaceutical products. It offers turnkey projects tailored. The company is headquartered in Longueuil, Canada. | Health Technology |
LSL Pharma Group, Inc. | |
JAMP Pharma Corp.
JAMP Pharma Corp. Pharmaceuticals: GenericHealth Technology JAMP Pharma Corp. develops pharmaceutical products. The private company is based in Boucherville, Canada. The Canadian company was founded in 1988. The CEO is Louis Pilon. | Health Technology |
- Stock Market
- Insiders
- François Roberge
- Experience